Ernexa director granted options on 5,943 shares
Ernexa Therapeutics Inc. (ERNA) reported that director William A. Wexler received a grant of stock options for 5,943 shares of common stock.
Rhea-AI Filing Summary
Ernexa Therapeutics Inc. (ERNA) reported that director William A. Wexler received a grant of stock options for 5,943 shares of common stock. The options have an exercise price of $4.57 per share and expire on August 31, 2036. Following this grant, Wexler holds 5,943 stock options directly. Vesting is time-based: one-third of the underlying shares vest on the first anniversary of the grant date, with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 5,943 shares
Grant/Award
1 txn
Insider
Wexler William A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) F1 | 5,943 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 5,943 contracts (Direct)
Footnotes (1)
- F1. Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.
Key Figures
Stock options granted: 5,943 shares
Exercise price: $4.57 per share
Expiration date: August 31, 2036
+3 more
6 metrics
Stock options granted
5,943 shares
Number of stock option shares granted to William A. Wexler on 2026-08-31
Exercise price
$4.57 per share
Conversion or exercise price of the stock option granted on 2026-08-31
Expiration date
August 31, 2036
Expiration date of the granted stock option
Total options held after transaction
5,943 options
Total derivative shares following the reported grant for William A. Wexler
Initial vesting portion
One-third of 5,943 shares
Vests on the first anniversary of the grant date, subject to continued service
Remaining vesting installments
24 monthly installments
Remaining option shares vest in 24 substantially equal monthly installments after first anniversary
Key Terms
Stock Option (Right to buy), exercise price, expiration date, underlying security, +1 more
5 terms
Stock Option (Right to buy) financial
"security_title: Stock Option (Right to buy)"
exercise price financial
"conversion_or_exercise_price: 4.5700"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-08-31"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
vesting financial
"shares underlying the stock option will vest in 24 substantially equal monthly"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did director William A. Wexler report in this Form 4 for ERNA?
He reported a grant of stock options for 5,943 shares of Ernexa Therapeutics Inc. common stock, with an exercise price of $4.57 per share and an expiration date of August 31, 2036.
Is the Form 4 transaction for ERNA a purchase or a grant of options?
The Form 4 discloses a grant/award acquisition of a stock option, not an open-market purchase or sale. The transaction code is A, indicating a grant or other acquisition of derivative securities.
What is the vesting schedule of William A. Wexler’s ERNA stock options?
The options vest based on continued service: one-third of the underlying shares vest on the first anniversary of the grant date, and the remaining shares vest in 24 substantially equal monthly installments thereafter.
What is the exercise price and expiration date of the ERNA options granted?
The options have an exercise price of $4.57 per share and an expiration date of August 31, 2036, as disclosed in the Form 4 transaction details.
How many ERNA stock options does William A. Wexler hold after this transaction?
After this grant, William A. Wexler directly holds 5,943 stock options of Ernexa Therapeutics Inc., according to the Form 4’s “total shares following transaction” field.
AI-generated analysis. How Rhea-AI works. Not financial advice.
